The article presents various real-life scenarios that doctors encounter, such as the decision to withhold or withdraw life-sustaining treatment, dealing with patients who refuse life-saving interventions due to personal beliefs, and grappling with the consequences of medical errors. These ethical challenges often leave physicians torn between their duty to heal and respecting patient autonomy. The personal accounts of physicians reveal the deep emotional impact and moral distress caused by these dilemmas. Feelings of guilt, burnout, and loss of professional identity are common repercussions, leading some doctors to reconsider their career paths or experience profound emotional exhaustion.
Author: Abhay Panchal
A bill in the Maine legislature would have the medical malpractice statute of limitations clock start running when a patient discovers the negligence, which could be years after treatment took place. And other states could follow suit with similar bills. What danger does this pose for doctors? As it stands, the time limit for patients to be able to bring a medical malpractice lawsuit varies by state. The bill that was introduced in Maine would enable patients to bring suits many years after treatment took place. For physicians, this extends their period of liability and could potentially increase the number…
Here are 10 gastroenterology groups who have grown their footprint so far in 2023:
Four experts share what you need to know about the role of endoscopy in recurrent acute and chronic pancreatitis.
During the esophagus session at the AGA Postgraduate Course 2023, significant updates in esophagology were presented. Key highlights include novel care approaches for esophageal diseases, such as GERD, extraesophageal reflux, and Barrett’s esophagus, based on recent AGA best practice updates. Additionally, randomized clinical trial data examined therapeutic approaches for erosive esophagitis and eosinophilic esophagitis. One notable finding was the effectiveness of potassium competitive acid blockers, which demonstrated faster and stronger suppression of gastric acid secretion compared to traditional PPI therapy for healing erosive esophagitis, a critical step in preventing further complications.
Google Cloud and Mayo Clinic have announced a groundbreaking partnership to harness generative AI and Enterprise Search for healthcare improvement. Mayo clinicians and researchers will gain access to Google’s HIPAA-compliant tools, enabling more efficient data navigation and curated search results. This collaboration holds great potential for revolutionizing healthcare by providing quick access to complex data sets, enhancing treatment strategies, and empowering clinicians with advanced search capabilities.
According to the article, the American College of Gastroenterology (ACG) and the American Gastroenterological Association (AGA) have invested in Oshi Health to accelerate the adoption of hybrid digestive health care. This collaboration between Oshi Health and both leading gastroenterology specialty medical associations aims to provide dietary and behavioral health interventions as recommended by guidelines, in a high-touch, iterative care delivery model that is proven to improve outcomes and is ideally suited for virtual delivery. The AGA GI Opportunity Fund’s investment in Oshi Health is intended to improve the lives of digestive health patients by improving their access to multidisciplinary care…
According to a study published in Clinical Gastroenterology and Hepatology, offering a blood test to people who have declined both a colonoscopy and a fecal immunochemical test (FIT) increased colorectal cancer (CRC) screening by 7.5% without decreasing use of the preferred first-line options. The study enrolled 359 veterans at a Veterans Affairs (VA) medical center. Participants were 50–75 years old and were eligible for screening but had declined a colonoscopy and a stool test within the previous 6 months. The blood test is easy to perform and requires only a few tubes of blood, no diet restrictions, test prep, or…
The article states that US Digestive Health has announced the addition of four new providers to its gastroenterology practice. The new providers will be located in the Northeast and will provide cutting-edge care and personalized treatment plans to more patients than any other provider in the region. US Digestive Health is the leading gastroenterology practice in the Northeast and one of the largest in the United States. It was formed in 2019 by Amulet Capital Partners, LP, a healthcare private equity investment firm based in Greenwich, Connecticut, in partnership with member practice partner physicians.
A new study by Harvard Medical School investigators at Massachusetts General Hospital has linked certain types of gut bacteria to the development of precancerous colon polyps. Their results are published in Cell Host & Microbe. “Researchers have done a lot of work to understand the relationship between the gut microbiome and cancer. But this new study is about understanding the microbiome’s influence on precancerous polyps,” said co-corresponding author Daniel C. Chung, HMS professor of medicine, medical co-director of the Center for Cancer Risk Assessment at Mass General Cancer Center, and a faculty member of the gastroenterology division at Mass General.